Dusseldorf - Delayed Quote EUR

Cidara Therapeutics Inc (20D.DU)

9.19 +8.73 (+1,900.00%)
At close: April 23 at 7:30 PM GMT+2
Key Events
Loading Chart for 20D.DU
DELL
  • Previous Close 0.46
  • Open 0.52
  • Bid 0.46 x --
  • Ask 0.52 x --
  • Day's Range 0.46 - 9.19
  • 52 Week Range 0.46 - 26.32
  • Volume 2,000
  • Avg. Volume 9
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 9, 2024 - May 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 20D.DU

Cidara buys back rights to flu therapy from J&J for $85m

Cidara buys back rights to flu therapy from J&J for $85m

Performance Overview: 20D.DU

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

20D.DU
35.72%
S&P 500
6.92%

1-Year Return

20D.DU
49.66%
S&P 500
25.26%

3-Year Return

20D.DU
74.18%
S&P 500
22.00%

5-Year Return

20D.DU
--
S&P 500
56.97%

Compare To: 20D.DU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 20D.DU

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    53.71M

  • Enterprise Value

    24.90M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.67

  • Price/Book (mrq)

    7.64

  • Enterprise Value/Revenue

    0.39

  • Enterprise Value/EBITDA

    -1.02

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Company Insights: 20D.DU